MaxLinear — 2026Q4 earnings
reported 2026-10-22
EPS $0.62 vs $0.56 est — beat
Revenue $218.1M vs $210.2M est — beat
next session -2.8% (close 2026-10-22 → 2026-10-23)
Financial flow diagram
Reported amounts; ribbons scale proportionally within each node. Negative free cash flow represents a funding gap.
Quarter-only operating cash-flow reconciliation is unavailable. Segment revenue breakdown is not available in the statement adapter. Segment capital expenditure breakdown is not disclosed in the parsed tables.
View data and sources
| Item | Amount |
|---|---|
| Revenue | 2180.57 |
| Operating profit | 302.27 |
| Net income | 289.02 |
| Operating cash flow | — |
| Capex | — |
| Free cash flow | — |
| Research & development | 606.42 |
| Selling & administration | 369.47 |
| Restructuring | 2.54 |
| Other operating costs (derived) | 899.87 |
| Interest expense | -26.92 |
| Interest income | 4.65 |
| Other income / expense | 1.70 |
| Other non-operating items (derived) | 7.32 |
The dollar-denominated release uses USD, verified against the same issuer's preceding inline-XBRL statement.
Other operating costs are revenue less operating income and the separately disclosed costs.
Other non-operating items reconcile operating income to consolidated net income.